AccutarBio is based in Brooklyn, New York. It has raised $100M in total funding. Latest round: Series C.
AccutarBio funding overview
AccutarBio is based in Brooklyn, New York. AccutarBio has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in April 2021. The round record for AccutarBio runs through 2021; nothing later has been disclosed. Investors on record include Yunfeng Capital, Coatue, 3W Healthcare Fund, ZhenFund, IDG Capital, YITU Technology and 2 others. 8 distinct backers are named across the disclosed rounds.
AccutarBio has raised $100M in total disclosed funding across the rounds on record.
Who has invested in AccutarBio?
Yunfeng Capital, Coatue, 3W Healthcare Fund, ZhenFund, IDG Capital, YITU Technology are named among the investors backing AccutarBio.
What was the latest AccutarBio funding round?
The most recent disclosed round is a Series C, announced in April 2021.
Where is AccutarBio based?
AccutarBio is based in Brooklyn, New York.
When did AccutarBio last raise?
The last disclosed AccutarBio round closed in April 2021 at Series C.
AccutarBio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Brooklyn below to benchmark round size and investor mix.
